Cullinan Therapeutics (CGEM) Shares Outstanding (2020 - 2026)
Cullinan Therapeutics (CGEM) Shares Outstanding (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 198.10 Mn |
| 10 | Cullinan Therapeutics | 378.25 Mn | 378.25 Mn | - | 21.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.33 Mn |
| Dec 31, 2025 | 21.06 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Jun 30, 2025 | 20.70 Mn |
| Mar 31, 2025 | 19.55 Mn |
| Dec 31, 2024 | 15.76 Mn |
| Sep 30, 2024 | 58.34 Mn |
| Jun 30, 2024 | 55.05 Mn |
| Mar 31, 2024 | 43.01 Mn |
| Dec 31, 2023 | 41.55 Mn |
| Sep 30, 2023 | 42.73 Mn |
| Jun 30, 2023 | 39.95 Mn |
| Mar 31, 2023 | 40.68 Mn |
| Dec 31, 2022 | 45.16 Mn |
| Sep 30, 2022 | 45.61 Mn |
| Jun 30, 2022 | 44.87 Mn |
| Mar 31, 2022 | 44.43 Mn |
| Dec 31, 2021 | 43.08 Mn |
| Sep 30, 2021 | 43.44 Mn |
| Jun 30, 2021 | 43.30 Mn |